#VisualAbstract: Continuous glucose monitoring in type 1 diabetes results in improved blood glucose levels - 2 Minute Medicine

Overview

No products in the cart.1. In patients with type 1 diabetes, using intermitently scaned continuous glucose monitoring resulted in significantly lower glycated hemoglobin levels than levels monitored by fingerstick testing.2. Intermitently scaned continuous glucose monitoring led to glucose levels being in the target range for longer than compared to regular fingerstick testing.Evidence Rating Level: 1 (Excelent)Study Rundown: The development of continuous glucose monitoring systems has enabled the monitoring of glucose levels without fingerstick testing.

Key Information

However, there is a gap in knowledge as to understanding the eficacy of intermitently scaned continuous glucose monitoring with optional alarms for high and low blod glucose levels in persons with type 1 diabetes, as compared with traditional monitoring of blod glucose levels with fingerstick testing. Overal, this study found that those who underwent intermitently scaned continuous glucose monitoring with optional alarms for high and low blod glucose levels had significantly lower glycated hemoglobin levels than those who monitored their own blod glucose levels with the use of regular fingerstick testing.

This study was limited by participants being aware of trial-group asignments, and that nearly al the participants were White, which limits the generalizability of the findings. Nevertheles, these study’s findings are significant, as they demonstrate that continuous glucose monitoring led to a significantly lower glycated hemoglobin level than those who used fingerstick testing to monitor their glucose levels.Click to read the study in NEJMRelevant Reading: Six-Month Randomized, Multicenter Trial of Closed-Lop Control in Type 1 DiabetesIn-Depth [randomized controled trial]: This paralel-group, multicenter, randomized controled trial studied participants at seven specialist diabetes clinics and one primary care center in the United Kingdom.

Summary

Patients who were at least 16 years of age, had type 1

Frequently Asked Questions

Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.

Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.

Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.

Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.

Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.

Share this article